First Tracks Biotherapeutics Files Initial Ownership Statement
Ticker: TRAX · Form: 3 · Filed: Apr 23, 2026 · CIK: 0002091349
Sentiment: neutral
Topics: insider-filing, ownership
TL;DR
First Tracks Biotherapeutics filed a Form 3 on 4/23/26. New ownership info incoming.
AI Summary
On April 23, 2026, First Tracks Biotherapeutics, Inc. filed a Form 3, an initial statement of beneficial ownership of securities. The filing was made by Ajim Tamboli, who is listed as a reporting person. The period of report for this filing is April 17, 2026.
Why It Matters
This filing indicates a new ownership disclosure for First Tracks Biotherapeutics, Inc., which could signal changes in the company's insider holdings.
Risk Assessment
Risk Level: low — A Form 3 filing is a standard initial disclosure of beneficial ownership and does not inherently represent a change in company performance or risk.
Key Players & Entities
- First Tracks Biotherapeutics, Inc. (company) — Issuer
- Ajim Tamboli (person) — Reporting Person
- MONTE ROSA THERAPEUTICS, INC. (company) — Mailing Address
FAQ
What type of SEC filing is this?
This is a Form 3, an initial statement of beneficial ownership of securities.
Who is the issuer in this filing?
The issuer is First Tracks Biotherapeutics, Inc.
When was the filing date?
The filing date was April 23, 2026.
What is the period of report for this filing?
The period of report is April 17, 2026.
Who is listed as the reporting person?
Ajim Tamboli is listed as the reporting person.
Filing Details
This Initial Statement of Beneficial Ownership (Form 3) was filed with the SEC on April 23, 2026 by Ajim Tamboli regarding First Tracks Biotherapeutics, Inc. (TRAX). Form 3 filings establish the initial ownership position of company insiders when they first assume their role.